191 related articles for article (PubMed ID: 23434935)
1. Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.
Menne J; Shushakova N; Bartels J; Kiyan Y; Laudeley R; Haller H; Park JK; Meier M
Diabetes; 2013 Apr; 62(4):1167-74. PubMed ID: 23434935
[TBL] [Abstract][Full Text] [Related]
2. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
4. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.
Menne J; Park JK; Boehne M; Elger M; Lindschau C; Kirsch T; Meier M; Gueler F; Fiebeler A; Bahlmann FH; Leitges M; Haller H
Diabetes; 2004 Aug; 53(8):2101-9. PubMed ID: 15277392
[TBL] [Abstract][Full Text] [Related]
5. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
7. Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Cox AJ; Qi W; Thai K; Pollock CA; Christensen PK; Parving HH; Gilbert RE
Diabetologia; 2008 Apr; 51(4):668-74. PubMed ID: 18278479
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway.
Haneda M; Koya D; Kikkawa R
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S178-81. PubMed ID: 11576950
[TBL] [Abstract][Full Text] [Related]
9. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
Tuttle KR; Anderson PW
Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
[TBL] [Abstract][Full Text] [Related]
10. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of renal gene expression of protein kinase C (PKC) isoforms in diabetic and nondiabetic proliferative glomerular diseases.
Ibrahim S; Rashed L; Fadda S
ScientificWorldJournal; 2008 Aug; 8():835-44. PubMed ID: 18758661
[TBL] [Abstract][Full Text] [Related]
13. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
14. Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.
Meier M; Menne J; Haller H
Diabetologia; 2009 May; 52(5):765-75. PubMed ID: 19238353
[TBL] [Abstract][Full Text] [Related]
15. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of protein kinase C isoforms in coronary arteries of diabetic mice lacking the G-protein Gα11.
Hoyer DP; Korkmaz Y; Grönke S; Addicks K; Wettschureck N; Offermanns S; Reuter H
Cardiovasc Diabetol; 2010 Dec; 9():93. PubMed ID: 21190563
[TBL] [Abstract][Full Text] [Related]
18. Tandem inhibition of PKC in Diαβetic nephropathy: it takes two to tango?
Thallas-Bonke V; Cooper ME
Diabetes; 2013 Apr; 62(4):1010-1. PubMed ID: 23520273
[No Abstract] [Full Text] [Related]
19. d-alpha-tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of protein kinase C-diacylglycerol pathway.
Koya D; Haneda M; Kikkawa R; King GL
Biofactors; 1998; 7(1-2):69-76. PubMed ID: 9523030
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
